Danish pharma huge Novo Nordisk teased promising early-stage demo results of its experimental weight loss pill amycretin, sending the business’s stock surging.GLP-one agonist medications, usually known as GLP-1s, are injectable medicines that function by mimicking the GLP-one hormone that your tiny intestine tends to make in reaction to foods, fo… Read More